Stockreport

Starpharma’s SPL7013 Shows Significant Activity Against SARS-CoV-2 (coronavirus)

STARPHARMA HLDGS S/ADR  (SPHRY) 
NASDAQ:AMEX Investor Relations: starpharma.com/investor_centre
PDF Starpharma’s antiviral dendrimer, SPL7013, has been shown to have significant activity against SARS-CoV-21 (coronavirus), which causes COVID-19 SPL7013 is the active com [Read more]